Anti-Inflammatory Drugs Industry Anticipated to Expand at 10.8% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Anti-Inflammatory Drugs Market By 2029?

The market for anti-inflammatory drugs has experienced rapid expansion in recent years. Its value is projected to increase from $136.86 billion in 2024 to $152.08 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.1%. The growth observed in the past can be ascribed to factors like a progressively aging population, the escalating prevalence of chronic inflammatory conditions, greater accessibility of over-the-counter medications, increasing understanding of pain management, and the broader development of healthcare infrastructure.

The anti-inflammatory drugs market is projected to experience substantial expansion over the next few years. It is forecast to grow to $228.83 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.8%. This growth during the forecast period is primarily driven by factors such as the rising incidence of autoimmune diseases, increasing demand for personalized medicine, an expanding geriatric population, supportive government initiatives, and a growing preference for topical and targeted therapies. Prominent trends expected in this period include innovations in biologic drugs, a strategic shift towards biologics and biosimilars, the rise of telemedicine prescriptions, the integration of AI in drug discovery, ongoing R&D in novel anti-inflammatory mechanisms, and continued innovation in targeted anti-inflammatory therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Industry Drivers Are Expected To Accelerate The Anti-Inflammatory Drugs Market From 2025 To 2029?

The increasing occurrence of arthritis is projected to propel the expansion of the anti-inflammatory drugs market in the coming years. Arthritis is defined as the inflammation of one or more joints, manifesting as pain, swelling, and stiffness that typically worsens with age. The growing incidence of arthritis is primarily attributed to aging populations; as individuals grow older, the natural wear and tear on joints increases, leading to a greater likelihood of developing the condition. Anti-inflammatory drugs assist in managing arthritis by alleviating joint inflammation and pain, enabling patients to maintain better mobility and perform daily activities with greater ease, thereby enhancing their overall quality of life. For instance, in March 2023, according to the Office for Health Improvement and Disparities, a UK-based government department, in 2022, 17.6% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition, such as arthritis or a persistent back or joint issue, which rose from 17.0% in 2021. Therefore, the rising prevalence of arthritis is a key driver for the growth of the anti-inflammatory drugs market.

What Are The Emerging Segments Gaining Attention In The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

What Trends Are Redefining The Anti-Inflammatory Drugs Market Dynamics?

Major companies operating in the anti-inflammatory drugs market are prioritizing the creation of advanced formulations, such as topical solutions, to facilitate precise delivery and improve patient adherence. A topical solution, which is a liquid medicine applied directly to the skin or the affected region, aids anti-inflammatory medications by locally delivering their active components, thereby alleviating inflammation at the site while mitigating systemic adverse effects. For instance, in December 2022, Lupin Limited, an India-based pharmaceutical company, introduced the approved generic equivalent of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) from Horizon Pharma Therapeutics in the United States. This initiative aimed to broaden its U.S. generics portfolio and enhance access to economical anti-inflammatory treatments. This particular drug, classified as a nonsteroidal anti-inflammatory medication, is employed to manage pain associated with osteoarthritis of the knee, providing localized relief through its topical application and reducing the systemic side effects often associated with oral NSAIDs.

Who Are The Top Performing Companies In The Anti-Inflammatory Drugs Market In Recent Years?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

What Regional Growth Trends Are Shaping The Anti-Inflammatory Drugs Market Outlook?

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Anti-Inflammatory Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2025, By The Business Research Company

Veterinary Orthopedic Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Pediatric Orthopedic Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-orthopedic-implants-global-market-report

Orthopedic Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795